Type I interferon antagonism of the JMJD3-IRF4 pathway modulates macrophage activation and polarization
Author(s) -
Ming-Chin Lee,
Adrian Achuthan,
David P. De Souza,
Tanya Lupancu,
Katrina J. Binger,
Man K.S. Lee,
Yangsong Xu,
Malcolm J. McConville,
Nicole A. de Weerd,
Dragana Dragoljevic,
Paul J. Hertzog,
Andrew Murphy,
John A. Hamilton,
Andrew J. Fleetwood
Publication year - 2022
Publication title -
cell reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2022.110719
Subject(s) - antagonism , macrophage polarization , interferon , microbiology and biotechnology , biology , macrophage , chemistry , cancer research , genetics , in vitro , receptor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom